Reading additional input from stdin...
OpenAI Codex v0.144.6
--------
workdir: /home/administrator/Documents/promotion/claudius-proteomics
model: gpt-5.6-terra
provider: openai
approval: never
sandbox: read-only
reasoning effort: medium
reasoning summaries: none
session id: 01a037af-8836-7970-bec6-e1885df2017a
--------
user
This is a v5 REFRAME of an ECCB 2026 poster plan (#1015, Posters track) you reviewed twice before. The author is INVERTING the spine: from a proteomics case study to a general thesis about trusting AI-written scientific software, with proteomics/proteon/cu-ims demoted to use-cases and concrete deliverables (a CC0 corpus + trained models) as the payoff. Rationale: MS proteomics is niche at ECCB; a poster is a conversation-starter so an explorative opinion is acceptable IF epistemic status is worn openly (the poster tags every claim Verified/Judged/Absent). Give a tight, skeptical review. Answer the 5 numbered questions at the end of the brief directly and concretely. Then: (a) is this reframe a net improvement or a net risk vs the proteomics-anchored v4? (b) the single most important thing to get right. (c) any NEW overclaim the inversion introduces. Cap ~750 words.

<stdin>
# ECCB 2026 poster #1015 — v5 REFRAME brief (for review)

**The pivot (from v4).** v1–v4 framed the poster as a *proteomics-infrastructure*
case study with EVIDENT/typed-trust as the remedy. v5 **inverts the spine**: the
poster is now about **AI-assisted scientific software validation in general** —
"how do you trust code, configs, and results an AI wrote that you didn't author
and don't fully understand" — and **proteomics is demoted to one of three
use-cases**, retaining the single *measured* result as the empirical anchor.

**Why.** ECCB is broad computational biology (genomics / structural / systems /
ML-for-bio); MS proteomics is niche there. The general thesis draws the whole
room; the concrete deliverables + one measured result reward the specialists who
stop by. It is a **poster** (a conversation-starter), so an explorative,
opinionated thesis is acceptable *provided the epistemic status is worn openly* —
which is exactly what the poster's Verified/Judged/Absent tagging device does:
every claim is labelled by how it was established, so the speculative parts are
marked Judged/Absent, not smuggled as fact.

## Draft abstract (~170 words, broad-first)
> Scientific software is increasingly written by AI faster than researchers can
> verify it. The bottleneck has moved from writing code to *trusting* it —
> especially code, configurations, and results you did not author and do not fully
> understand. Unit tests and successful-looking runs miss failures at
> configuration, deployment, and external-service boundaries, and these are
> invisible to review by humans and models alike.
>
> We present EVIDENT, a framework for typed trust: every assertion records how it
> was established — Verified (a reproducible procedure ran), Judged (an
> interpretation), or Absent (sought, not found) — with a deterministic final
> report that calls no model. It decouples a claim from the test that checks it,
> makes the oracle ("what do we check against?") explicit, and turns things an
> agent did that you don't understand into verified additions to your knowledge
> base.
>
> We ground it in three single-author, AI-assisted systems — proteomics,
> structural biology, GPU signal-processing — including a measured case where one
> configuration silently drove two search engines to search different spaces on 25
> of 128 datasets, caught only by the rendered artifact.

## The framework, given the spine (4 patterns)
1. **Typed trust** — Verified / Judged / Absent; deterministic synthesis (verdict calls no model).
2. **Claim ⊥ test** — a manifest binds claim → oracle → tolerance → command → artifact; tests attach/are challenged without rewriting the claim.
3. **The oracle pattern** — what to check against with no ground truth: reproducible check · cross-tool agreement (correlated, *not* an oracle) · simulator truth · declared tolerance · manifest-as-oracle.
4. **Verification as learning** — unknown agent output → extract claim → verify against an oracle → fold the verified fact into your knowledge base.

## The empirical anchor (unchanged, measured — kept as the credibility heart)
One `mod_profile` → two search engines searched different modification spaces on
**25 of 128 paired datasets** (Sage PTM-aware, FragPipe PTM-blind); one-sided
(25 vs 0). Verified from rendered configs, versions recovered, run-linked (A9
provenance supplement). A **deterministic conformance gate** is built + deployed,
exits 2 pre-search, emits a Verified/Judged/Absent TrustReport (A6/A10 done). Plus
two more failure classes (silent no-op override; silent API null zeroing 191/544
datasets) and a provenance metric (100% of 150 runs `working_tree_dirty`).

## Use-cases (the pattern generalizes — Judged, n=1)
- **proteomics** (claudius) — the measured anchor; oracle = cross-engine agreement.
- **proteon** — structural biology, Rust, pip-published; declared tolerances + a release-tier typed-trust claim on CHARMM19+BALL electrostatics.
- **cu-ims** — GPU diaPASEF; oracle = simulator truth + CPU/CUDA bit-parity; honestly behind SOTA on depth.
One author, ~250k LOC, three domains.

## Concrete deliverables (the payoff — real, usable)
- **HF corpus** — public 100% CC0 timsTOF reference layer (v0.2: 58 datasets, 33.7 M precursors, 504 M b/y fragments; v0.3 acyl-PTM increment building now).
- **timsTOF property predictors** — RT / ion-mobility / intensity / CCS, trained on the corpus, on the imspy_predictors hub (models-v0.6.0; best fine-tune SA 0.798, CCS MAE 0.0148, RT r 0.918).

## Honesty posture / novelty
Contribution positioned as **a small, executable conformance gate + explicit
evidence-status rendering** — not a new provenance model. Prior art cited: W3C
PROV, Workflow Run RO-Crate, MLflow/DVC, differential + metamorphic testing.
Stated exploratory: n=1, no control, author = developer = analyst = subject;
"AI-assisted" is the setting, not a measured variable.

## Questions for review
1. Is inverting the spine to "general AI-assisted-software trust," with proteomics
   demoted to one of three use-cases and only ONE measured result, defensible for
   a poster — or does it hollow out the empirical ground?
2. Is the "explorative opinion is fine for a poster session, as long as V/J/A tags
   the epistemic status" stance sound, or a rationalization for over-claiming?
3. Are the 4 framework patterns (esp. "verification as learning" and "claim ⊥
   test") genuinely distinct from differential/metamorphic testing + PROV/RO-Crate,
   or repackaging? Which single pattern is the real contribution?
4. Do the concrete deliverables (corpus + models) actually strengthen the poster,
   or read as a bolted-on advertisement disconnected from the trust thesis?
5. Biggest risk that a broad ECCB audience (not proteomics) would puncture.
</stdin>
codex
1. **Defensible, but only as a hypothesis-driven poster—not evidence for a general thesis.** One measured proteomics failure can anchor an argument that this class of boundary error exists and that EVIDENT caught one instance. It cannot substantiate general claims across AI-assisted scientific software, three domains, or human/model review. Keep proteomics visibly central as the sole evaluated case; label the other systems as design probes/examples, not use-cases demonstrating generalization.

2. **Sound only if tagging constrains the rhetoric, not merely decorates it.** V/J/A is useful provenance for statements, but it does not convert a Judged generalization into empirical support. The title, abstract opening, take-home box, and verbal pitch must all obey the tags. “Explorative” is acceptable; “scientific software is increasingly written by AI faster than researchers can verify it” and “invisible to review by humans and models alike” are broad factual claims needing evidence or softening.

3. **Mostly repackaging, with one potentially useful integration.**  
   - Differential/metamorphic testing already cover several “no ground truth” checks.  
   - PROV/RO-Crate and reproducibility systems already represent provenance and artifacts.  
   - “Verification as learning” is a compelling metaphor/workflow, not yet a distinct technical contribution.  
   - “Claim ⊥ test” is familiar good testing architecture unless the manifest has a demonstrated capability unavailable from conventional test metadata.

   The real contribution is **executable, claim-level evidence-status rendering coupled to a deterministic conformance gate**. That is concrete, demoable, and appropriately modest.

4. **They strengthen it only if made evidence-bearing.** As written, the CC0 corpus and predictors risk reading as an unrelated portfolio panel. Connect them explicitly: show one or two model/data claims represented in the same manifest, their oracle, artifact, and V/J/A output. Otherwise, move them to a small “systems built with this practice” footer—or omit them. “Real, usable” is not itself evidence that the trust framework works.

5. **Biggest broad-audience puncture:** “Where is the evaluation?” A visitor will ask whether EVIDENT reduces undetected failures, improves review, or transfers beyond one author’s proteomics pipeline. The honest answer is: not yet measured. Put that answer on the poster before they ask: one measured incident, no comparative study, no claim of improved reliability, and a proposed evaluation protocol.

**(a) Net improvement or risk vs v4:** Net improvement for ECCB attention and conversation, but a **net scientific-risk increase**. It succeeds only if the poster is framed as a sharply bounded position plus one executable case study, rather than a general validation solution.

**(b) Single most important thing:** Keep the scope boundary unmistakable: **the gate is evaluated on one proteomics configuration-conformance problem; general AI-assisted trust is the motivating question, not the demonstrated conclusion.**

**(c) New overclaim introduced:** The inversion invites the claim that EVIDENT makes AI-generated work trustworthy—or turns incomprehensible agent output into verified knowledge generally. It demonstrably verifies only claims with a valid, explicitly chosen oracle. Crucially, cross-tool agreement is not an oracle for scientific correctness; in the measured case, the rendered intended configuration/conformance specification is the oracle.
tokens used
6,321
1. **Defensible, but only as a hypothesis-driven poster—not evidence for a general thesis.** One measured proteomics failure can anchor an argument that this class of boundary error exists and that EVIDENT caught one instance. It cannot substantiate general claims across AI-assisted scientific software, three domains, or human/model review. Keep proteomics visibly central as the sole evaluated case; label the other systems as design probes/examples, not use-cases demonstrating generalization.

2. **Sound only if tagging constrains the rhetoric, not merely decorates it.** V/J/A is useful provenance for statements, but it does not convert a Judged generalization into empirical support. The title, abstract opening, take-home box, and verbal pitch must all obey the tags. “Explorative” is acceptable; “scientific software is increasingly written by AI faster than researchers can verify it” and “invisible to review by humans and models alike” are broad factual claims needing evidence or softening.

3. **Mostly repackaging, with one potentially useful integration.**  
   - Differential/metamorphic testing already cover several “no ground truth” checks.  
   - PROV/RO-Crate and reproducibility systems already represent provenance and artifacts.  
   - “Verification as learning” is a compelling metaphor/workflow, not yet a distinct technical contribution.  
   - “Claim ⊥ test” is familiar good testing architecture unless the manifest has a demonstrated capability unavailable from conventional test metadata.

   The real contribution is **executable, claim-level evidence-status rendering coupled to a deterministic conformance gate**. That is concrete, demoable, and appropriately modest.

4. **They strengthen it only if made evidence-bearing.** As written, the CC0 corpus and predictors risk reading as an unrelated portfolio panel. Connect them explicitly: show one or two model/data claims represented in the same manifest, their oracle, artifact, and V/J/A output. Otherwise, move them to a small “systems built with this practice” footer—or omit them. “Real, usable” is not itself evidence that the trust framework works.

5. **Biggest broad-audience puncture:** “Where is the evaluation?” A visitor will ask whether EVIDENT reduces undetected failures, improves review, or transfers beyond one author’s proteomics pipeline. The honest answer is: not yet measured. Put that answer on the poster before they ask: one measured incident, no comparative study, no claim of improved reliability, and a proposed evaluation protocol.

**(a) Net improvement or risk vs v4:** Net improvement for ECCB attention and conversation, but a **net scientific-risk increase**. It succeeds only if the poster is framed as a sharply bounded position plus one executable case study, rather than a general validation solution.

**(b) Single most important thing:** Keep the scope boundary unmistakable: **the gate is evaluated on one proteomics configuration-conformance problem; general AI-assisted trust is the motivating question, not the demonstrated conclusion.**

**(c) New overclaim introduced:** The inversion invites the claim that EVIDENT makes AI-generated work trustworthy—or turns incomprehensible agent output into verified knowledge generally. It demonstrably verifies only claims with a valid, explicitly chosen oracle. Crucially, cross-tool agreement is not an oracle for scientific correctness; in the measured case, the rendered intended configuration/conformance specification is the oracle.
